<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00851513</url>
  </required_header>
  <id_info>
    <org_study_id>BRD08/6-B</org_study_id>
    <nct_id>NCT00851513</nct_id>
  </id_info>
  <brief_title>Therapeutic Effects Analysis of Pudendal Nerve Infiltrations After 3 Months, in Patients Suffering of Pudendal Neuralgia</brief_title>
  <acronym>INFILTHERA</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nantes University Hospital</source>
  <brief_summary>
    <textblock>
      Pudendal neuralgia is a recent identified pathology, extremely invalidating, related to
      chronic pelvic entrapment. Nowadays, pudendal neuralgia can be treated with:

        -  neuropathic pains treatment

        -  specific kinesitherapy

        -  Alcock's canal and sacrospinal ligament infiltrations under scan

        -  with diagnostic block

        -  local steroids injections

        -  and surgical decompression of pudendal nerve with transrectal approach.

      Only surgery was validated after a randomised protocol studying surgery versus abstention,
      performed and published by the CHU de Nantes. Many techniques have been proposed for
      realization of pudendal nerve infiltrations. The results of these infiltrations have never
      been published, and no randomised study had ever evaluated those results, even at short-run.
      Very few randomized studies have validated steroids infiltrations techniques in canal
      syndrome neuropathies.

      The primary objective of the investigators phase IV trial is to evaluate the efficacy of
      three different types of pudendal nerve infiltrations in Alcock's canal and sacrospinal
      ligament:

        -  group A: only local anesthetic (control arm)

        -  group B: local anesthetics associated with local steroids

        -  group C: local anesthetics associated with local steroids and important volumes of
           physiological serum
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2008</start_date>
  <completion_date type="Actual">February 2011</completion_date>
  <primary_completion_date type="Actual">February 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The main objective is to evaluate, after 3 months, the therapeutical efficacy on pain of steroids pudendal nerve infiltration, in patients suffering from pudendal neuralgia with canal syndrome</measure>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">202</enrollment>
  <condition>Pudendal Neuralgia</condition>
  <condition>Canal Syndrome</condition>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>local anesthetics (lidocaine) associated with local steroids (depo-medrol)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>local anesthetics (lidocaine) associated with local steroids (depomedrol) and important volumes of physiological serum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>only local anesthetic (lidocaine)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>local anesthetics</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Depmedrol</intervention_name>
    <description>local steroids</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>physiological serum</intervention_name>
    <description>important volumes of physiological serum</description>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient presenting the four indispensable clinical criteria for pudendal neuralgia
             (Nantes' criteria)

          -  Man or woman aged more than 18 years old

          -  Suffering from pudendal neuralgia since more than six months

          -  Without previous infiltration identical to the one proposed by the protocol

          -  Without previous surgery of pudendal nerve

          -  Without any hemorrhagic risk factor

          -  No contra-indication to Lidocaïne, Depo-medrol or contrast-product injections

          -  Pain intensity with an average &gt; or = 40/100 (measured by scales during the fifteen
             days before infiltration)

        Exclusion Criteria:

          -  Patient presenting one of the four exclusion clinical criterium for pudendal neuralgia
             (Nantes' criteria)

          -  Patient who has filled his &quot;pain note book&quot; during less than 5 days over the 15 days
             before the infiltration

          -  Pregnancy

          -  Depression (Beck scale &gt; 16/39)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Jacques LABAT</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nantes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH de la Côte Basque</name>
      <address>
        <city>Bayonne</city>
        <zip>64100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre MARIENIA</name>
      <address>
        <city>Cambo les Bains</city>
        <zip>64250</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63058</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Lyon</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catherine de Sienne</name>
      <address>
        <city>Nantes</city>
        <zip>44200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75571</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scanner Saint Hilaire</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 25, 2009</study_first_submitted>
  <study_first_submitted_qc>February 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2009</study_first_posted>
  <last_update_submitted>September 2, 2013</last_update_submitted>
  <last_update_submitted_qc>September 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 4, 2013</last_update_posted>
  <keyword>Pudendal neuralgia</keyword>
  <keyword>pudendal nerve</keyword>
  <keyword>Alcock's canal syndrome</keyword>
  <keyword>Canal syndrome</keyword>
  <keyword>neuropathic pain</keyword>
  <keyword>infiltration</keyword>
  <keyword>randomized protocol</keyword>
  <keyword>pain scales</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Pudendal Neuralgia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

